Skip to main content
. 2019 Jun 12;3(2):pkz031. doi: 10.1093/jncics/pkz031

Table 1.

Distribution of all adolescent and young adult cancers by time period, tumor, and patient characteristics, California, 1988–2014

Characteristic Distribution, %
1988–2000 2001–2014
(n = 107 747) (n = 117 746)
Cancer site
 Bone and soft tissue sarcoma 2.4 2.7
 Brain and CNS: Benign 3.9
 Brain and CNS: Invasive 4.2 4.1
 Breast 14.1 13.8
 Cervix 6.2 4.5
 Colorectal 3.7 4.8
 Kaposi sarcoma 8.5 1.0
 Kidney 1.1 2.1
 Leukemia: ALL 1.3 1.8
 Leukemia: AML 1.7 1.9
 Leukemia: CML 0.9 0.9
 Lip, oral cavity, and pharynx 1.6 1.6
 Lung 1.8 1.3
 Lymphoma: Hodgkin 5.0 5.1
 Lymphoma: Non-Hodgkin 7.5 5.8
 Melanoma 10.6 9.1
 Ovary: Carcinoma 1.6 1.4
 Ovary: Germ cell 0.5 0.6
 Stomach 1.1 1.1
 Testis 7.5 8.5
 Thyroid 7.8 12.4
 Uterus 1.1 1.8
 Other* 9.8 9.7
Stage
 Localized 46.5 51.6
 Regional 21.6 25.4
 Distant 21.1 18.8
 In situ 0.2 0.5
 Unknown 10.7 3.7
Sex
 Male 46.9 40.7
 Female 53.1 59.3
 Other or unknown 0.0 0.0
Age group, y
 15–19 5.1 7.1
 20–24 8.5 11.2
 25–29 16.6 16.8
 30–34 28.5 25.8
 35–39 41.2 39.1
Race and ethnicity
 Asian and Pacific Islander 7.3 9.8
 Black 6.9 5.7
 Latino white 23.1 33.5
 Non-Latino white 59.5 45.9
 Other or unknown 3.2 5.1
Socioeconomic status
 High 21.3 20.3
 Mid-high 22.7 21.7
 Middle 20.9 20.4
 Mid-low 18.5 19.4
 Low 16.6 18.2
*

Other indicates all noncategorized invasive cancers and benign intracranial tumors. See Supplementary Table 2 (available online) for cancer sites included in other. Of the other cancers, 2% and 5.5% are in situ stage in 1988–2000 and 2001–2014, respectively. ALL = acute lymphocytic leukemia; AML = acute myeloid leukemia; CML = chronic myeloid leukemia; CNS = central nervous system.